» Authors » Izabela Szczuka

Izabela Szczuka

Explore the profile of Izabela Szczuka including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 74
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sopel M, Kuberka I, Szczuka I, Taradaj J, Rosinczuk J, Dymarek R
Biomedicines . 2024 Feb; 12(2). PMID: 38397961
Wound healing requires the coordinated interaction of dermis cells, the proper deposition of extracellular matrix, re-epithelialization, and angiogenesis. Extracorporeal shock wave (ESW) is a promising therapeutic modality for chronic wounds....
2.
Bednarczyk-Cwynar B, Leskow A, Szczuka I, Zaprutko L, Diakowska D
Pharmaceuticals (Basel) . 2023 May; 16(5). PMID: 37242529
This study aimed to synthesize four new semisynthetic derivatives of natural oleanolic acid (OA) and, based on an analysis of their cytotoxic and anti-proliferative effects against human MeWo and A375...
3.
Lewandowska P, Szczuka I, Bednarz-Misa I, Szczesniak-Siega B, Neubauer K, Mierzchala-Pasierb M, et al.
Molecules . 2021 Dec; 26(23). PMID: 34885960
The mechanisms underlying the antineoplastic effects of oxicams have not been fully elucidated. We aimed to assess the effect of classic and novel oxicams on the expression/secretion of macrophage-associated chemokines...
4.
Szczuka I, Wierzbicki J, Serek P, Szczesniak-Siega B, Krzystek-Korpacka M
Biomolecules . 2021 Nov; 11(11). PMID: 34827586
Heat shock proteins HSPA1/Hsp70α and HSP90AA1/Hsp90α are crucial for cancer growth but their expression pattern in colorectal polyps or whether they can be modulated by oxicams is unknown. We quantified...
5.
Leskow A, Tarnowska M, Szczuka I, Diakowska D
Sci Rep . 2021 Sep; 11(1):19568. PMID: 34580413
No abstract available.
6.
Leskow A, Tarnowska M, Szczuka I, Diakowska D
Sci Rep . 2021 Sep; 11(1):18660. PMID: 34548551
Molluscs are one of the sources of biologically active substances, which are now intensively studied, especially for their anti-cancer properties. Malignant melanoma originates from melanocytes, develops very quickly and is...
7.
Krzystek-Korpacka M, Szczesniak-Siega B, Szczuka I, Fortuna P, Zawadzki M, Kubiak A, et al.
Cancers (Basel) . 2020 Sep; 12(9). PMID: 32932854
L-arginine/nitric oxide pathway metabolites are altered in colorectal cancer (CRC). We evaluated underlying changes in pathway enzymes in 55 paired tumor/tumor-adjacent samples and 20 normal mucosa using quantitative-PCR and assessed...
8.
Szczuka I, Wisniewski J, Kustrzeba-Wojcicka I, Terlecki G
Adv Clin Exp Med . 2020 Aug; 29(8):949-957. PMID: 32820873
Background: Cathepsin B (CTSB, EC 3.4.22.1) is a protease that physiologically resides in lysosomes and whose biosynthesis, cell surface location, intracellular distribution, and enzymatic activity undergo changes during the pathogenesis...
9.
Bednarz-Misa I, Diakowska D, Szczuka I, Fortuna P, Kubiak A, Rosinczuk J, et al.
Cancers (Basel) . 2020 Jun; 12(6). PMID: 32512917
Immunosuppressive interleukins (IL)-4 and 13 may directly promote cancer but neither their status nor role in gastrointestinal tract is clarified. We aim at quantifying ILs and their receptors in paired...
10.
Krzystek-Korpacka M, Fleszar M, Bednarz-Misa I, Lewandowski L, Szczuka I, Kempinski R, et al.
Int J Mol Sci . 2020 Mar; 21(5). PMID: 32121248
L-arginine/nitric oxide pathway in Crohn's disease (CD) and ulcerative colitis (UC) is poorly investigated. The aim of current study is to quantify pathway serum metabolites in 52 CD (40 active),...